胍基化壳聚糖作为多功能增强剂改善氟比洛芬的递送。

IF 1.7 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Nowshin Farzana Khan, Hideaki Nakamura, Hironori Izawa, Tsuyoshi Ikeda, Shinsuke Ifuku, Masaki Otagiri, Makoto Anraku
{"title":"胍基化壳聚糖作为多功能增强剂改善氟比洛芬的递送。","authors":"Nowshin Farzana Khan, Hideaki Nakamura, Hironori Izawa, Tsuyoshi Ikeda, Shinsuke Ifuku, Masaki Otagiri, Makoto Anraku","doi":"10.1248/bpb.b25-00394","DOIUrl":null,"url":null,"abstract":"<p><p>In this study, we investigated guanidinylated chitosan (GCS), a chemically modified derivative of unmodified low-molecular-weight chitosan (CS), as a multifunctional excipient to enhance the solubility and absorption of poorly water-soluble drugs. Flurbiprofen (FP) was selected as a model drug to compare the performance of kneaded dispersions GCS-based (FP-GCS) and CS-based (FP-CS). Both GCS and CS increased the solubility of FP in a concentration-dependent manner, with no significant differences between them. However, dissolution testing showed that FP-GCS kneaded dispersion significantly enhanced the dissolution rate of FP alone in water and simulated gastric fluid (pH 1.2), but not under simulated intestinal conditions (pH 6.8). In vivo pharmacokinetic studies in rats demonstrated that FP-GCS kneaded dispersion achieved the highest plasma concentration of FP, suggesting enhanced gastrointestinal permeability. Moreover, FP-GCS kneaded dispersion markedly reduced gastric ulceration in a rat ulcer model. These results indicate that GCS is an effective oral drug delivery excipient capable of improving both the bioavailability and gastrointestinal safety of FP.</p>","PeriodicalId":8955,"journal":{"name":"Biological & pharmaceutical bulletin","volume":"48 8","pages":"1246-1254"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Guanidinylated Chitosan as a Multifunctional Enhancer for Improved Flurbiprofen Delivery.\",\"authors\":\"Nowshin Farzana Khan, Hideaki Nakamura, Hironori Izawa, Tsuyoshi Ikeda, Shinsuke Ifuku, Masaki Otagiri, Makoto Anraku\",\"doi\":\"10.1248/bpb.b25-00394\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In this study, we investigated guanidinylated chitosan (GCS), a chemically modified derivative of unmodified low-molecular-weight chitosan (CS), as a multifunctional excipient to enhance the solubility and absorption of poorly water-soluble drugs. Flurbiprofen (FP) was selected as a model drug to compare the performance of kneaded dispersions GCS-based (FP-GCS) and CS-based (FP-CS). Both GCS and CS increased the solubility of FP in a concentration-dependent manner, with no significant differences between them. However, dissolution testing showed that FP-GCS kneaded dispersion significantly enhanced the dissolution rate of FP alone in water and simulated gastric fluid (pH 1.2), but not under simulated intestinal conditions (pH 6.8). In vivo pharmacokinetic studies in rats demonstrated that FP-GCS kneaded dispersion achieved the highest plasma concentration of FP, suggesting enhanced gastrointestinal permeability. Moreover, FP-GCS kneaded dispersion markedly reduced gastric ulceration in a rat ulcer model. These results indicate that GCS is an effective oral drug delivery excipient capable of improving both the bioavailability and gastrointestinal safety of FP.</p>\",\"PeriodicalId\":8955,\"journal\":{\"name\":\"Biological & pharmaceutical bulletin\",\"volume\":\"48 8\",\"pages\":\"1246-1254\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biological & pharmaceutical bulletin\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1248/bpb.b25-00394\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological & pharmaceutical bulletin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1248/bpb.b25-00394","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

在本研究中,我们研究了胍基化壳聚糖(GCS),一种未经改性的低分子量壳聚糖(CS)的化学修饰衍生物,作为一种多功能赋形剂,以提高水溶性差的药物的溶解度和吸收。以氟比洛芬(FP)为模型药物,比较GCS-based (FP- gcs)和CS-based (FP- cs)捏合分散体的性能。GCS和CS均以浓度依赖的方式增加FP的溶解度,两者之间无显著差异。然而,溶出度测试表明,FP- gcs捏合分散体可显著提高FP在水和模拟胃液(pH 1.2)中的溶出率,而在模拟肠道条件(pH 6.8)下则无明显作用。大鼠体内药代动力学研究表明,FP- gcs揉捏弥散剂的血浆FP浓度最高,表明其增强了胃肠道通透性。此外,FP-GCS揉捏弥散剂可显著减少大鼠溃疡模型的胃溃疡。这些结果表明,GCS是一种有效的口服给药赋形剂,能够提高FP的生物利用度和胃肠道安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Guanidinylated Chitosan as a Multifunctional Enhancer for Improved Flurbiprofen Delivery.

In this study, we investigated guanidinylated chitosan (GCS), a chemically modified derivative of unmodified low-molecular-weight chitosan (CS), as a multifunctional excipient to enhance the solubility and absorption of poorly water-soluble drugs. Flurbiprofen (FP) was selected as a model drug to compare the performance of kneaded dispersions GCS-based (FP-GCS) and CS-based (FP-CS). Both GCS and CS increased the solubility of FP in a concentration-dependent manner, with no significant differences between them. However, dissolution testing showed that FP-GCS kneaded dispersion significantly enhanced the dissolution rate of FP alone in water and simulated gastric fluid (pH 1.2), but not under simulated intestinal conditions (pH 6.8). In vivo pharmacokinetic studies in rats demonstrated that FP-GCS kneaded dispersion achieved the highest plasma concentration of FP, suggesting enhanced gastrointestinal permeability. Moreover, FP-GCS kneaded dispersion markedly reduced gastric ulceration in a rat ulcer model. These results indicate that GCS is an effective oral drug delivery excipient capable of improving both the bioavailability and gastrointestinal safety of FP.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.50
自引率
5.00%
发文量
247
审稿时长
2 months
期刊介绍: Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信